BE850204A - Analogues nouveaux de prostaglandines - Google Patents
Analogues nouveaux de prostaglandinesInfo
- Publication number
- BE850204A BE850204A BE173933A BE173933A BE850204A BE 850204 A BE850204 A BE 850204A BE 173933 A BE173933 A BE 173933A BE 173933 A BE173933 A BE 173933A BE 850204 A BE850204 A BE 850204A
- Authority
- BE
- Belgium
- Prior art keywords
- prostaglandins
- new analogues
- analogues
- new
- Prior art date
Links
- 229940094443 oxytocics prostaglandins Drugs 0.000 title 1
- 150000003180 prostaglandins Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/04—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
- C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
- C07C405/0016—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing only hydroxy, etherified or esterified hydroxy groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
- C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
- C07C405/0025—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing keto groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
- C07C57/30—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
- C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4056—Esters of arylalkanephosphonic acids
- C07F9/4059—Compounds containing the structure (RY)2P(=X)-(CH2)n-C(=O)-(CH2)m-Ar, (X, Y = O, S, Se; n>=1, m>=0)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/54—Quaternary phosphonium compounds
- C07F9/5407—Acyclic saturated phosphonium compounds
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Crystallography & Structural Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US05/647,357 US4055602A (en) | 1976-01-08 | 1976-01-08 | 2-Decarboxy-2-hydroxy-methyl-5-oxa-17-phenyl-18,19,20-trinor-PGF-analogs |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE850204A true BE850204A (fr) | 1977-07-07 |
Family
ID=24596656
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE173933A BE850204A (fr) | 1976-01-08 | 1977-01-07 | Analogues nouveaux de prostaglandines |
Country Status (9)
| Country | Link |
|---|---|
| US (20) | US4055602A (fr) |
| JP (1) | JPS5289649A (fr) |
| AU (1) | AU502587B2 (fr) |
| BE (1) | BE850204A (fr) |
| CH (1) | CH627725A5 (fr) |
| DE (1) | DE2659215A1 (fr) |
| FR (1) | FR2337712A1 (fr) |
| NL (1) | NL7700117A (fr) |
| ZA (1) | ZA767465B (fr) |
Families Citing this family (45)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4183870A (en) * | 1974-01-26 | 1980-01-15 | May & Baker Limited | Cyclopentane derivatives |
| US4048058A (en) * | 1975-08-13 | 1977-09-13 | Standard Oil Company (Indiana) | Methods to be used in reforming processes employing multi-metallic catalysts |
| US4638100A (en) * | 1976-01-08 | 1987-01-20 | The Upjohn Company | Aromatic or inter-oxa 2-decarboxy-2-hydroxymethyl-PGFα compounds |
| US4208538A (en) * | 1976-01-08 | 1980-06-17 | The Upjohn Company | 2-Decarboxy-2-hydroxymethyl-3,7-inter-m-phenylene-ω-phenyl-PGF2 compounds |
| DE2655004C3 (de) * | 1976-12-02 | 1980-06-19 | Schering Ag, 1000 Berlin Und 4619 Bergkamen | Verfahren zur Herstellung von bicyclischen Laktonen |
| US5030621A (en) * | 1987-04-23 | 1991-07-09 | Bystryn Jean Claude | Shed melanoma antigen compositions |
| US5972991A (en) | 1992-09-21 | 1999-10-26 | Allergan | Cyclopentane heptan(ene) oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents |
| US5352708A (en) * | 1992-09-21 | 1994-10-04 | Allergan, Inc. | Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents |
| US5688819A (en) * | 1992-09-21 | 1997-11-18 | Allergan | Cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents |
| US20030060878A1 (en) * | 2001-08-31 | 2003-03-27 | Shadduck John H. | Intraocular lens system and method for power adjustment |
| US8048155B2 (en) | 2002-02-02 | 2011-11-01 | Powervision, Inc. | Intraocular implant devices |
| US8328869B2 (en) | 2002-12-12 | 2012-12-11 | Powervision, Inc. | Accommodating intraocular lenses and methods of use |
| US7637947B2 (en) | 2002-12-12 | 2009-12-29 | Powervision, Inc. | Accommodating intraocular lens system having spherical aberration compensation and method |
| US8361145B2 (en) | 2002-12-12 | 2013-01-29 | Powervision, Inc. | Accommodating intraocular lens system having circumferential haptic support and method |
| US10835373B2 (en) | 2002-12-12 | 2020-11-17 | Alcon Inc. | Accommodating intraocular lenses and methods of use |
| US7217288B2 (en) | 2002-12-12 | 2007-05-15 | Powervision, Inc. | Accommodating intraocular lens having peripherally actuated deflectable surface and method |
| EP1599748A4 (fr) | 2003-03-06 | 2007-10-24 | John H Shadduck | Lentille optique adaptative et procede de fabrication |
| US7306580B2 (en) * | 2003-04-16 | 2007-12-11 | Cook Incorporated | Medical device with therapeutic agents |
| WO2005095263A2 (fr) | 2004-03-24 | 2005-10-13 | H. C. Starck Inc. | Procedes de formation de films de tantale alpha et beta a nouvelles microstructures modulees |
| US20060292324A1 (en) * | 2004-03-26 | 2006-12-28 | Robert Roberts | Uniaxially and biaxially-oriented polytetrafluoroethylene structures |
| US7183310B2 (en) * | 2004-08-10 | 2007-02-27 | Allergan, Inc. | Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents |
| US7906552B2 (en) * | 2004-08-10 | 2011-03-15 | Allergan, Inc. | Cyclopentane heptan(ENE)OIC acid, 2-heteroarylalkenyl derivatives as therapeutic agents |
| US9872763B2 (en) | 2004-10-22 | 2018-01-23 | Powervision, Inc. | Accommodating intraocular lenses |
| US9241918B2 (en) | 2005-03-16 | 2016-01-26 | Allergan, Inc. | Enhanced bimatoprost ophthalmic solution |
| US7851504B2 (en) * | 2005-03-16 | 2010-12-14 | Allergan, Inc. | Enhanced bimatoprost ophthalmic solution |
| EP2112932B1 (fr) | 2007-02-21 | 2014-12-17 | PowerVision, Inc. | Matériaux polymères appropriés pour des dispositifs ophtalmiques et procédés de fabrication |
| CA2696450C (fr) | 2007-07-23 | 2016-02-16 | Alcon Inc. | Systeme de livraison de lentille |
| AU2008279167B2 (en) | 2007-07-23 | 2014-10-09 | Alcon Inc. | Post-implant lens power modification |
| US8314927B2 (en) * | 2007-07-23 | 2012-11-20 | Powervision, Inc. | Systems and methods for testing intraocular lenses |
| EP2671541B1 (fr) | 2007-07-23 | 2019-04-17 | PowerVision, Inc. | Accommodation de lentilles intraoculaires |
| US8668734B2 (en) | 2010-07-09 | 2014-03-11 | Powervision, Inc. | Intraocular lens delivery devices and methods of use |
| US8968396B2 (en) | 2007-07-23 | 2015-03-03 | Powervision, Inc. | Intraocular lens delivery systems and methods of use |
| US10299913B2 (en) | 2009-01-09 | 2019-05-28 | Powervision, Inc. | Accommodating intraocular lenses and methods of use |
| CA2768154C (fr) | 2009-07-13 | 2018-02-13 | Irix Pharmaceuticals | Synthese de prostanoides |
| WO2011026068A2 (fr) * | 2009-08-31 | 2011-03-03 | Powervision, Inc. | Estimation de la taille de la capsule du cristallin |
| US9522153B2 (en) | 2009-12-22 | 2016-12-20 | Allergan, Inc. | Compositions and methods for lowering intraocular pressure |
| WO2011106435A2 (fr) | 2010-02-23 | 2011-09-01 | Powervision, Inc. | Fluide pour recevoir des lentilles intraoculaires |
| ES2875049T3 (es) | 2011-03-24 | 2021-11-08 | Alcon Inc | Sistemas de carga de lentes intraoculares y métodos de uso |
| US10433949B2 (en) | 2011-11-08 | 2019-10-08 | Powervision, Inc. | Accommodating intraocular lenses |
| EP3785668A1 (fr) | 2013-03-15 | 2021-03-03 | Alcon Inc. | Dispositifs de stockage et de chargement de lentille intra-oculaire et procédés d'utilisation |
| KR102311896B1 (ko) | 2013-09-30 | 2021-10-14 | 패턴 에이피아이 서비시즈 인코포레이티드 | 복분해를 사용하는 프로스타글란딘 및 프로스타글란딘 중간체의 합성 경로 |
| CN107635511A (zh) | 2015-06-10 | 2018-01-26 | 力景公司 | 人工晶状体材料和组分 |
| CN111407464B (zh) | 2015-11-06 | 2022-12-13 | 爱尔康公司 | 可调节人工晶状体和制造方法 |
| JP2022550478A (ja) | 2019-10-04 | 2022-12-01 | アルコン インコーポレイティド | 調整可能な眼内レンズ及び手術後に眼内レンズを調整するための方法 |
| BR112023018612A2 (pt) | 2021-04-06 | 2023-10-24 | Alcon Inc | Aparelho, sistemas e métodos para avaliar objetivamente a acomodação em um olho |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3959346A (en) * | 1969-03-14 | 1976-05-25 | The Upjohn Company | Racemic prostaglandins of the 2-series and analogs thereof |
| DE2317019A1 (de) * | 1972-04-27 | 1973-11-08 | Upjohn Co | Neue 4,5-didehydro-prostaglandine |
| US3914282A (en) * | 1973-01-16 | 1975-10-21 | Upjohn Co | Prostaglandin E{HD 1{B , F{HD 1{B , and A{HD 1 {B analogs |
| US3962293A (en) * | 1973-07-20 | 1976-06-08 | The Upjohn Company | 13,14-Dihydro-16-fluoro prostaglandin F1 |
| US3932463A (en) * | 1974-06-03 | 1976-01-13 | American Cyanamid Company | 11-Deoxy-13-dihydro-prostaglandin-9-ketals |
-
1976
- 1976-01-08 US US05/647,357 patent/US4055602A/en not_active Expired - Lifetime
- 1976-12-15 ZA ZA767465A patent/ZA767465B/xx unknown
- 1976-12-16 CH CH1586776A patent/CH627725A5/de not_active IP Right Cessation
- 1976-12-21 AU AU20771/76A patent/AU502587B2/en not_active Expired
- 1976-12-28 DE DE19762659215 patent/DE2659215A1/de not_active Withdrawn
-
1977
- 1977-01-07 FR FR7700428A patent/FR2337712A1/fr active Granted
- 1977-01-07 NL NL7700117A patent/NL7700117A/xx not_active Application Discontinuation
- 1977-01-07 JP JP44377A patent/JPS5289649A/ja active Pending
- 1977-01-07 BE BE173933A patent/BE850204A/fr not_active IP Right Cessation
- 1977-08-05 US US05/822,031 patent/US4107215A/en not_active Expired - Lifetime
- 1977-08-05 US US05/822,025 patent/US4108902A/en not_active Expired - Lifetime
- 1977-08-05 US US05/822,035 patent/US4110382A/en not_active Expired - Lifetime
- 1977-08-05 US US05/822,038 patent/US4110383A/en not_active Expired - Lifetime
- 1977-08-05 US US05/822,301 patent/US4110384A/en not_active Expired - Lifetime
- 1977-08-05 US US05/822,020 patent/US4108900A/en not_active Expired - Lifetime
- 1977-08-05 US US05/822,033 patent/US4107212A/en not_active Expired - Lifetime
- 1977-08-05 US US05/822,305 patent/US4113778A/en not_active Expired - Lifetime
- 1977-08-05 US US05/822,036 patent/US4127733A/en not_active Expired - Lifetime
- 1977-08-05 US US05/822,024 patent/US4115454A/en not_active Expired - Lifetime
- 1977-08-05 US US05/822,037 patent/US4108903A/en not_active Expired - Lifetime
- 1977-08-05 US US05/822,299 patent/US4111995A/en not_active Expired - Lifetime
- 1977-08-05 US US05/822,300 patent/US4107211A/en not_active Expired - Lifetime
- 1977-08-05 US US05/822,302 patent/US4107213A/en not_active Expired - Lifetime
- 1977-08-05 US US05/822,303 patent/US4111996A/en not_active Expired - Lifetime
- 1977-08-05 US US05/822,023 patent/US4108901A/en not_active Expired - Lifetime
- 1977-08-05 US US05/822,027 patent/US4107214A/en not_active Expired - Lifetime
- 1977-08-05 US US05/822,034 patent/US4107216A/en not_active Expired - Lifetime
- 1977-08-05 US US05/822,026 patent/US4110381A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| US4108901A (en) | 1978-08-22 |
| US4055602A (en) | 1977-10-25 |
| US4111995A (en) | 1978-09-05 |
| NL7700117A (nl) | 1977-07-12 |
| US4107216A (en) | 1978-08-15 |
| AU2077176A (en) | 1978-06-29 |
| US4107212A (en) | 1978-08-15 |
| DE2659215A1 (de) | 1977-07-21 |
| US4110382A (en) | 1978-08-29 |
| US4113778A (en) | 1978-09-12 |
| US4127733A (en) | 1978-11-28 |
| US4107214A (en) | 1978-08-15 |
| FR2337712B1 (fr) | 1983-05-20 |
| US4107215A (en) | 1978-08-15 |
| US4115454A (en) | 1978-09-19 |
| US4110381A (en) | 1978-08-29 |
| US4111996A (en) | 1978-09-05 |
| JPS5289649A (en) | 1977-07-27 |
| FR2337712A1 (fr) | 1977-08-05 |
| AU502587B2 (en) | 1979-08-02 |
| US4107213A (en) | 1978-08-15 |
| ZA767465B (en) | 1977-11-30 |
| US4108900A (en) | 1978-08-22 |
| US4108902A (en) | 1978-08-22 |
| US4107211A (en) | 1978-08-15 |
| US4110384A (en) | 1978-08-29 |
| US4110383A (en) | 1978-08-29 |
| US4108903A (en) | 1978-08-22 |
| CH627725A5 (de) | 1982-01-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FR2337712A1 (fr) | Analogues nouveaux de prostaglandines | |
| BE857761A (fr) | Analogues de prostaglandines et leur preparation | |
| BE844105A (fr) | Analogues de prostaglandines et leur preparation | |
| BE846340A (fr) | Analogues de prostaglandines et leur preparation | |
| FR2337714A1 (fr) | Nouveaux analogues de prostaglandines | |
| BE846876A (fr) | Nouveaux analogues des prostaglandines et leur preparation, | |
| BE825459A (fr) | Nouveaux derives de prostaglandines | |
| FR2336924A1 (fr) | Analogues de prostaglandines et leur preparation | |
| BE856099A (fr) | Nouveaux analogues de prostaglandines et leur preparation | |
| FR2337713A1 (fr) | Analogues de prostaglandines | |
| BE854271A (fr) | Analogues de prostaglandines et leur preparation | |
| BE824196A (fr) | Prostaglandines | |
| BE851303A (fr) | Nouveaux derives bicycloalkyliques de prostaglandines | |
| BE857482A (fr) | Nouveaux analogues de cephalosporines | |
| BE851357A (fr) | Analogues des prostaglandines | |
| FR2299022A1 (fr) | Antagonistes de prostaglandines | |
| FR2320084A1 (fr) | Analogues de prostaglandines | |
| BE853801A (fr) | Analogues de prostaglandines et leur preparation | |
| FR2351100A1 (fr) | Nouveaux analogues de prostaglandines | |
| PT64737A (fr) | Prostaglandin analogues | |
| BE835430A (fr) | Nouveaux analogues des prostaglandines | |
| BE857161A (fr) | Nouveaux analogues de prostaglandines et leur preparation | |
| BE856739A (fr) | Composes analogues aux prostaglandines | |
| FR2289182A1 (fr) | Analogues de prostaglandines | |
| BE852363A (fr) | Analogues de prostaglandines |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RE | Patent lapsed |
Owner name: THE UPJOHN CY Effective date: 19860131 |